Mednet Logo
HomePediatric Hematology/OncologyQuestion

What therapy would you give to an AML patient with induction failure while awaiting HSCT?

1 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Baylor College of Medicine

I generally think of induction failure like relapse. You know you are dealing with chemoresistant disease so something from the "salvage" menu is appropriate. One of the most promising treatments to come along for relapsed/refractory disease in a long time is CPX-351 (Vyxeos). This was studied by th...

Register or Sign In to see full answer